METOPIRONE caps 250 mg bte 50 pce

7680278670148 CH-27867 V04CD01 07.07.4.

Reimbursement limitations:

METOPIRON

Pour le traitement du Syndrome de Cushing pour l’hypercortisolisme sans cause diagnostiquée, pour les patients …

METOPIRONE caps 250 mg bte 50 pce
METOPIRONE caps 250 mg bte 50 pce
METOPIRONE caps 250 mg bte 50 pce
1 / 3
google

Details

Product number
2786701
CPT
-
Packaging group
50
Unit
Kapsel(n)
Composition
metyraponum 250.00 mg, macrogolum 400, glycerolum (85 per centum), aqua purificata, macrogolum 4000, Kapselhülle: gelatina, glycerolum (85 per centum), E 171, E 215 0.71 mg, ethylvanillinum, propylis parahydroxybenzoas natricus 0.35 mg, 4-methoxyacetophenonum, Drucktinte: E 120, aluminii chloridum hexahydricum, natrii hydroxidum, hypromellosum, propylenglycolum, pro capsula corresp. natrium 0.13 mg.

Articles (1)

Metopiron, Kapseln
Kapseln
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
31/12/2024
Patient information leaflet
Français
31/12/2024
Patient information leaflet
Italien
31/12/2024
Professional SmPC
Allemand
31/12/2024
Professional SmPC
Français
31/12/2024
Professional SmPC
Italien
31/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
0.71 MG Substance HBESI
(N/A)
- Substance AIMDK
(N/A)
0.35 MG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
0.13 MG Substance HBESI

Reimbursement information

Public price
CHF 317.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2015

Authorization holder

EffRx Pharmaceuticals SA

8807 Freienbach

Authorization information

Swissmedic authorization number
27867
Drug name
Metopiron, Kapseln
Galenic form
KAPWE
ATC Code
V04CD01
Authorization status
Z
Dispensation category
B
First authorization
14/06/1961
Authorization expiration date
31/12/9999
IT number
07.07.4.
Domain
Human medicine
Field of application
Adrenocorticostaticum

Packaging details

Description (FR)
METOPIRONE caps 250 mg bte 50 pce
Description (DE)
METOPIRON Kaps 250 mg Ds 50 Stk
Market launch
14/06/1961
Narcotic (BTM)
No